BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

International Wex Technologies' (WXI) Tectin(TM) Study Results Show Efficacy In Pain Management; Phase IIa Final Results Announced At International Scientific Meeting


10/19/2005 5:11:14 PM

International Wex Technologies (TSX: WXI) today released the final results of its Phase IIa study of tetrodotoxin (Tectin(TM)), an investigational treatment for the management of severe cancer-related pain, at the 2nd Joint Scientific Meeting of the American Pain Society and the Canadian Pain Society being held in Vancouver, BC May 6-9, 2004. The Phase IIa results demonstrate that Tectin(TM), administered intramuscularly for four days at the studied doses, is well tolerated and can relieve refractory cancer pain for up to two weeks in some patients. Consistent with the interim analysis, the final results show that almost three-quarters (72 per cent) of cancer pain patients experienced a clinically meaningful analgesic response. The study was conducted in seven centers involving six Canadian cities: Saskatoon, Edmonton, Calgary, London, Montreal, and Toronto.

Read at CCNMatthews

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES